Olorid 0.1% (Ophthalmic Solution)

Indications

• Treatment of signs and symptoms of allergic conjunctivitis
• Relief of symptoms of seasonal allergic rhinitis
• Treatment of allergic rhinitis
• Relief of symptoms of allergic skin conditions

Pharmacology

• Antihistamine action
• Blocking action of histamine
• Reduction of allergy symptoms
• Mast cell stabilizer
• Antagonist at histamine H1 receptors

Dosage

• 0.1% eye drops: One drop in each affected eye two times per day
• 0.2% eye drops: One drop in the affected eye once a day
• 0.7% eye drops: One drop in each affected eye once a day
• Nasal spray for adults and adolescents: Two sprays per nostril twice daily
• Nasal spray for children 6 to 11 years old: One spray per nostril twice daily
• Tablet for adults: One tablet (5 mg) twice daily
• Tablet for children 7 years old or over: One tablet (5 mg) twice daily

Administration

• Instructions for using nasal spray
• Guidelines for cleaning the nasal spray

Interaction

No formal drug-drug interaction studies conducted for Nasal Spray

Contraindications

• Contraindicated in persons with known hypersensitivity
• Not recommended for use if allergic to it

Side Effects

• Headaches
• Blurred vision
• Burning or stinging
• Dry eye
• Nausea
• Pruritus
• Rhinitis
• Taste perversion

Pregnancy & Lactation

• Not teratogenic in rats and rabbits
• No adequate and well-controlled studies in pregnant women
• Caution should be exercised when administered to a nursing mother

Precautions & Warnings

• Advisory on wearing contact lenses
• Instructions for initial use of nasal spray
• Advisory on using Olonex Tablet as prescribed
• Advisory on not stopping medication without consulting a doctor

Use in Special Populations

No overall differences in safety or effectiveness observed in geriatric use

Overdose Effects

No specific information on Olorid overdose

Therapeutic Class

Ophthalmic Non-Steroid drugs

Storage Conditions

Store at room temperature and protect from light, use contents within one month after the first opening